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Triple Negative Breast Cancer (TNBC) has the worst prognosis among all the sub-types of 
breast cancer. Currently no targeted treatment has been approved for TNBC management. 
While TNBC does not overexpress hormone receptors, it has been found to over express 
certain receptors like transferrin (TfR) or folate receptors.  The aim of this research is to 
synthesize targeted polymeric nanoparticles for TNBC.  MDA-MB-231 cells are used as a 
representative TNBC cell line in this study. Active targeting of TNBC is achieved by conjugating 
the nanoparticles to a peptide (Tr) that binds to the TfR. Photodynamic Therapy (PDT) using 
polymeric nanoparticles was explored for TNBC treatment. PDT utilizes a secondary form of 
targeting by remotely triggering benzoporphyrin derivative monoacid (BPD) using near infrared 
light. When irradiated at 690nm, BPD induces cytotoxicity via generation of reactive oxygen 
species. The polymeric nanoparticles were characterized for size, zeta potential, and drug 
release at 37°C. The morphology of the nanoparticles was confirmed using electron microscopy 
and cell uptake was monitored in vitro using fluorescent microscopy. PDT was carried out at 
500nM BPD concentration using a 690nm laser. Cytotoxicity of these targeted polymeric 
nanoparticles was assessed using a standard colorimetric viability assay (MTT). The 
nanoparticles synthesized were fairly monodisperse and the release studies demonstrated 
sustained BPD release from the nanoparticles. Receptor mediated endocytosis of the active 
nanoparticles was studied by using FITC conjugated peptide and the FITC signal was observed 
using fluorescent microscopy. Stronger BPD fluorescent signal for the active targeting 
nanoparticles (PLGA-PEG-Tr) compared to the passive (PLGA-PEG) nanoparticles. Significant 
cell death following PDT was observed in all the treatment groups, which was also confirmed by 
imaging the cells post-treatment using standard live-dead stain. PDT is a fairly versatile and 
non-invasive form of treatment and using targeted nanoparticles it can be adapted for other 
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